Instadose Pharma (Instadose Pharma) Total Equity : $28.05 Mil (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Total Equity?

Instadose Pharma's total equity for the quarter that ended in Feb. 2022 was $28.05 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Instadose Pharma Total Equity Historical Data

The historical data trend for Instadose Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Total Equity Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Total Equity

Get a 7-Day Free Trial

-0.01

-0.03

-0.06

-0.08

-0.17

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Total Equity	Get a 7-Day Free Trial															-0.01	-0.06	-0.11	-0.17	28.05

Instadose Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Instadose Pharma's Total Equity for the fiscal year that ended in Nov. 2021 is calculated as

Total Equity	=	Total Assets(Q: Nov. 2021 )	-	Total Liabilities(Q: Nov. 2021 )
	=	N/A	-	0.165
	=	N/A

Instadose Pharma's Total Equity for the quarter that ended in Feb. 2022 is calculated as

Total Equity	=	Total Assets(Q: Feb. 2022 )	-	Total Liabilities(Q: Feb. 2022 )
	=	36.142	-	8.089
	=	28.05

Instadose Pharma Total Equity Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.